F
Foudil Lamari
Researcher at University of Paris
Publications - 94
Citations - 4154
Foudil Lamari is an academic researcher from University of Paris. The author has contributed to research in topics: Frontotemporal dementia & Medicine. The author has an hindex of 31, co-authored 80 publications receiving 3240 citations.
Papers
More filters
Journal ArticleDOI
CSF biomarker variability in the Alzheimer's Association quality control program
Niklas Mattsson,Niklas Mattsson,Ulf Andreasson,Staffan Persson,Maria C. Carrillo,Steven J. Collins,Sonia Chalbot,Neal Cutler,Diane Dufour-Rainfray,Anne M. Fagan,Niels H. H. Heegaard,Ging-Yuek Robin Hsiung,Bradley T. Hyman,Khalid Iqbal,D. Richard Lachno,Alberto Lleó,Piotr Lewczuk,José Luis Molinuevo,Piero Parchi,Axel Regeniter,Robert A. Rissman,Hanna Rosenmann,Giuseppe Sancesario,Johannes Schröder,Leslie M. Shaw,Charlotte E. Teunissen,John Q. Trojanowski,Hugo Vanderstichele,Manu Vandijck,Marcel M. Verbeek,Henrik Zetterberg,Henrik Zetterberg,Kaj Blennow,Stephan A. Käser,Aladro José A. Rojo,Marilyn S. Albert,Daniel Alcolea,Anna Antonell,Hiroyuki Arai,Silvana Archetti,Eva Arkblad,Inês Baldeiras,Ales Bartos,Dev Batish,Aurélie Bedel,Daniele Bentue-Ferrer,Flora Berisha,Sergio Bernardini,Marinus A. Blankenstein,Olivier Bousiges,Michael C. Camuso,Maria Berrocal Carrillo,Tiziana Casoli,Sebastiano Cavallaro,Odete A. da Cruz e Silva,Isabelle Cuvelier,Odile Delaroche,Roy B. Dyer,Sebastiaan Engelborghs,Anne Fogli,Orestes Vicente Forlenza,Nick C. Fox,Giovanni B. Frisoni,Daniela Galimberti,Elisabetta Galloni,Silvana Gritti,Karen H. Gylys,Harald Hampel,Sabine Haustein,Theresa Heath,Michael T. Heneka,Sanna-Kaisa Herukka,David M. Holtzman,Christian Humpel,Takeshi Iwatsubo,Claude Jardel,Mathias Jucker,Elisabeth Kapaki,Daniel Kidd,Péter Klivényi,Ryozo Kuwano,Foudil Lamari,Jean-Louis Laplanche,Jordan Laser,Sylvian Lehmann,Qiao-Xin Li,Walter Maetzler,Catherine Malaplate-Armand,Ralph Martin,Robert Martone,Colin L. Masters,Marc Mercken,Jose Luis Molinuevo,T. J. Montine,William Nowatzke,Markus Otto,Xavier Parent,Lucilla Parnetti,Ronald C. Petersen,Koen Poesen,Isabelle Quadrio,Muriel Quillard,Vara Luis Rello,Zdenek Rohan,Christin Sisowath,Anders Skinningsrud,Holly Soares,Hilkka Soininen,Knudsen Cindy Søndersø,Annette Spreer,Silvia Suardi,C.E. Teunissen,Robert M. Umek,Bianca Van Broeck,Rik Vandenberghe,László Vécsei,M.M. Verbeek,Igor Vostiar,Manfred Windisch +118 more
TL;DR: The cerebrospinal fluid biomarkers amyloid beta 1–42, total tau, and phosphorylated tau are used increasingly for Alzheimer's disease research and patient management, but there are large variations in biomarker measurements among and within laboratories.
Journal ArticleDOI
Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia
Rosalinde E.R. Slot,Sietske A.M. Sikkes,Johannes Berkhof,Henry Brodaty,Rachel F. Buckley,Rachel F. Buckley,Enrica Cavedo,Efthimios Dardiotis,Francoise Guillo-Benarous,Harald Hampel,Nicole A. Kochan,Simone Lista,Tobias Luck,Paul Maruff,José Luis Molinuevo,Johannes Kornhuber,Barry Reisberg,Steffi G. Riedel-Heller,Shannon L. Risacher,Susanne Roehr,Perminder S. Sachdev,Nikolaos Scarmeas,Nikolaos Scarmeas,Philip Scheltens,Melanie B. Shulman,Andrew J. Saykin,Sander C.J. Verfaillie,Pieter Jelle Visser,Pieter Jelle Visser,Stephanie J.B. Vos,Michael Wagner,Michael Wagner,Steffen Wolfsgruber,Steffen Wolfsgruber,Frank Jessen,Frank Jessen,Mercè Boada,Peter Paul De Deyn,Roy W. Jones,Giovanni B. Frisoni,L. Spiru,Flavio Nobili,Yvonne Freund-Levi,Hilkka Soininen,Frans R.J. Verhey,Åsa K. Wallin,Jacques Touchon,Marcel G. M. Olde Rikkert,Anne-Sophie Rigaud,Roger Bullock,Magda Tsolaki,Bruno Vellas,Gordon K. Wilcock,Lutz Froelich,Hovagim Bakardjian,Habib Benali,Hugo Bertin,Joel Bonheur,Laurie Boukadida,Nadia Boukerrou,Patrizia A. Chiesa,Olivier Colliot,Bruno Dubois,Marion Dubois,Stéphane Epelbaum,Geoffroy Gagliardi,Remy Genthon,M.-O. Habert,Marion Houot,Aurélie Kas,Foudil Lamari,Marcel Levy,Christiane Metzinger,Fanny Mochel,Francis Nyasse,Catherine Poisson,Marie-Claude Potier,Marie Revillon,Antonio Carlos dos Santos,Katia Andrade,Marine Sole,Mohmed Surtee,Michel Thiebaud de Schotten,Andrea Vergallo,Nadjia Younsi,Wiesje M. van der Flier +85 more
TL;DR: The incidence of Alzheimer's disease and non‐AD dementia and determinants of progression to dementia are assessed and subjective cognitive decline in community‐based and memory clinic settings is assessed.
Journal ArticleDOI
Neurofilament light chain: a biomarker for genetic frontotemporal dementia.
Lieke H.H. Meeter,Elise G.P. Dopper,Lize C. Jiskoot,Raquel Sánchez-Valle,Caroline Graff,Caroline Graff,Luisa Benussi,Roberta Ghidoni,Yolande A.L. Pijnenburg,Barbara Borroni,Daniela Galimberti,Robert Laforce,Mario Masellis,Mario Masellis,Rik Vandenberghe,Isabelle Le Ber,Markus Otto,Rick van Minkelen,Janne M. Papma,Serge A.R.B. Rombouts,Serge A.R.B. Rombouts,Mircea Balasa,Linn Öijerstedt,Linn Öijerstedt,Vesna Jelic,Vesna Jelic,Katrina M. Dick,David M. Cash,David M. Cash,S. Harding,M. Jorge Cardoso,Sebastien Ourselin,Martin N. Rossor,Alessandro Padovani,Elio Scarpini,Chiara Fenoglio,Maria Carmela Tartaglia,Foudil Lamari,Christian Barro,Jens Kuhle,Jonathan D. Rohrer,Charlotte E. Teunissen,John C. van Swieten,John C. van Swieten +43 more
TL;DR: To evaluate cerebrospinal fluid and serum neurofilament light chain levels in genetic frontotemporal dementia (FTD) as a potential biomarker in the presymptomatic stage and during the conversion into the symptomatic stage.
Journal ArticleDOI
Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia
Christelle Tesson,Magdalena Nawara,Magdalena Nawara,Magdalena Nawara,Mustafa A. Salih,Rodrigue Rossignol,Maha S. Zaki,Mohammed Al Balwi,Rebecca Schüle,Cyril Mignot,Emilie Obre,Ahmed Bouhouche,Filippo M. Santorelli,Christelle M. Durand,Andrés Caballero Oteyza,Khalid H. El-Hachimi,Abdulmajeed Al Drees,Naima Bouslam,Foudil Lamari,Salah A. Elmalik,Mohammad M. Kabiraj,Mohammed Zain Seidahmed,Typhaine Esteves,Typhaine Esteves,Typhaine Esteves,Marion Gaussen,Marion Gaussen,Marion Gaussen,Marie Lorraine Monin,Marie Lorraine Monin,Marie Lorraine Monin,Gabor Gyapay,Doris Lechner,Michael A. Gonzalez,Christel Depienne,Fanny Mochel,Julie Lavie,Ludger Schöls,Didier Lacombe,Mohamed Yahyaoui,Ibrahim Al Abdulkareem,Stephan Züchner,Atsushi Yamashita,Ali Benomar,Cyril Goizet,Alexandra Durr,Joseph G. Gleeson,Frédéric Darios,Frédéric Darios,Frédéric Darios,Alexis Brice,Giovanni Stevanin +51 more
TL;DR: It is demonstrated in human cells that the HSP pathophysiology includes alteration of mitochondrial architecture and bioenergetics with increased oxidative stress and focus attention on lipid metabolism as a critical HSP pathway with a deleterious impact on mitochondrial bioenergetic function.
Journal ArticleDOI
Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study
Bruno Dubois,Stéphane Epelbaum,Francis Nyasse,Hovagim Bakardjian,Geoffroy Gagliardi,Olga Uspenskaya,Marion Houot,Simone Lista,Federica Cacciamani,Marie-Claude Potier,Anne Bertrand,Foudil Lamari,Habib Benali,Jean-François Mangin,Olivier Colliot,Remy Genthon,Marie-Odile Habert,Harald Hampel,Christelle Audrain,Alexandra Auffret,Filippo Baldacci,Ismahane Benakki,Hugo Bertin,Laurie Boukadida,Enrica Cavedo,Patrizia A. Chiesa,Luce Dauphinot,Antonio Melo dos Santos,Marion Dubois,Stanley Durrleman,Gaëlle Fontaine,Alexis Genin,Pauline Glasman,Navichka Jungalee,Aurélie Kas,Maya Kilani,Valentina La Corte,Stéphane Lehéricy,Claire Letondor,Marcel Levy,Mark Lowrey,Juliette Ly,Ornella Makiese,Christiane Metzinger,Agnès Michon,Fanny Mochel,Catherine Poisson,Stephie Ratovohery,Marie Revillon,Katrine Rojkova,Perrine Roy,Katia Santos-Andrade,Rachel Schindler,Laure Seux,Valérie Simon,Marine Sole,Caroline Tandetnik,Marc Teichmann,Michel Thiebaut de Shotten,Nadjia Younsi +59 more
TL;DR: The INSIGHT-preAD study as discussed by the authors assessed associations between brain β-amyloidosis and various cognitive and neuroimaging parameters with progression of cognitive decline in individuals with preclinical Alzheimer's disease.